资讯
一点资讯 on MSN
首次人体实验成功！基因编辑胰岛细胞“隐身”植入，可分泌胰岛素
时令 发自 凹非寺 糖尿病治疗迎来新突破！ 最新研究显示，科学家首次将CRISPR编辑的胰岛细胞移植到一名1型糖尿病患者体内。 这些细胞不仅在数月内持续分泌胰岛素，还能逃避免疫检测，使植入接受者无需服用免疫抑制剂。 此研究于已发表在《新英格兰医学杂志 ...
1型糖尿病是一种 自身免疫性疾病 ，患者的免疫系统会错误地攻击胰腺中分泌胰岛素的细胞。 针对这一问题，华盛顿西雅图 Sana Biotechnology公司 提出了一项新研究，为全球约950万1型糖尿病病人带来了治愈的希望。
一点资讯 on MSN
当CRISPR打开“潘多拉魔盒”：动物基因编辑引发的全球激辩
记者：刘 霞 利用CRISPR基因编辑技术可提高马匹肌肉力量。图片来源：《自然》网站 随着CRISPR基因编辑技术的不断进步，科学家已将其应用于马、绵羊、猪等动物的遗传改良。
The placenta is a unique organ that exists only during pregnancy, growing at tumour-like speed to the size of a small dinner ...
Flagship Pioneering’s Lila Sciences has landed a substantial $235 million series A as it looks to exceed the current limits ...
The global research antibodies and reagents market is projected to grow at a CAGR of 7% from 2025 to 2030, driven by ...
The study will interest researchers studying genome organisation in mitosis. Genomes assume a complex 3D architecture in the interphase cell nucleus. Yet, the molecular mechanisms that determine ...
The field of microbiology has emerged as a cornerstone for green technology, playing a crucial role in fostering sustainable ...
CRISPR gene-edited cell therapy improves quality of life in patients with transfusion-dependent beta-thalassemia, research suggests.
Discover how Simplify Health Care ETF outperforms with active healthcare stock selection, offering alpha where others see ...
AZoLifeSciences on MSN
How Xenotransplantation Moved From Failed Experiments To Lifesaving Reality
Xenotransplantation, leveraging genetic engineering and CRISPR, offers a promising solution to the organ shortage crisis ...
来自国际顶尖团队的研究人员通过CRISPR-Cas9全基因组敲除筛选，发现脂肪酸延长酶ELOVL6可选择性降解KRAS-G12V突变蛋白，破坏其膜定位并抑制肿瘤生长。该研究揭示了KRAS突变癌细胞的代谢弱点，为开发首创新药靶向清除KRAS-G12V提供了理论依据。 这项突破性研究揭示了KRAS癌蛋白令人惊讶的代谢软肋。KRAS作为癌症中最常突变的原癌基因，其G12V热点突变一直缺乏有效靶向策略。通 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈